Journal of Bioremediation & Biodegradation
Open Access

Microalgae; Bioremediation; Emerging pollutants; Environmental remediation; Wastewater treatment

Introduction

Emerging pollutants, including pharmaceuticals, personal care products, pesticides, and industrial chemicals, continue to be introduced into the environment at an alarming rate. These compounds often evade conventional wastewater treatment processes and accumulate in ecosystems, posing risks to aquatic and terrestrial organisms as well as human populations. Microalgae, such as Chlorella, Spirulina, and Scenedesmus, have gained attention for their ability to metabolize and detoxify a wide range of pollutants through mechanisms including bioaccumulation, biosorption, and enzymatic degradation. This article reviews the potential of microalgal bioremediation as a sustainable approach to mitigate the impact of emerging pollutants.[1, 2]

Mechanisms of microalgal bioremediation

Microalgae possess inherent metabolic pathways that can transform organic pollutants into less harmful substances or store them in biomass. Photosynthetic activity enables microalgae to utilize carbon dioxide and nutrients from wastewater, enhancing their growth while simultaneously reducing pollutant concentrations. Some species can accumulate metals and organic pollutants intracellularly, making them suitable candidates for wastewater treatment and environmental remediation.[3]

Prospects of microalgal bioremediation

Efficiency and versatility: Microalgae exhibit high pollutant removal efficiencies and can simultaneously treat various types of pollutants present in complex wastewater streams.

Resource recovery: Bioremediation processes can facilitate the recovery of valuable resources such as lipids, proteins, and carbohydrates from microalgal biomass, contributing to economic viability.

Carbon sequestration: Utilization of CO2 during photosynthesis contributes to carbon sequestration, potentially offsetting greenhouse gas emissions. 

Low energy input: Compared to conventional treatment methods, microalgal bioremediation typically requires lower energy inputs, thus reducing operational costs and environmental footprint.

Obstacles and challenges

Scale-Up and Engineering Challenges: Transitioning from laboratory-scale studies to large-scale applications poses challenges related to cultivation, harvesting, and maintaining consistent pollutant removal efficiencies.

Cost: Despite potential economic benefits, initial capital investment and operational costs remain significant barriers to widespread adoption.[5,6]

Environmental conditions: Microalgal growth and pollutant removal efficiencies are influenced by environmental factors such as temperature, pH, nutrient availability, and light intensity, necessitating optimization for different pollutant types and geographical locations.

Regulatory frameworks: Lack of standardized regulations and guidelines specific to microalgal bioremediation may hinder commercial deployment and acceptance.

Emerging trends and future directions

Genetic engineering: Advances in genetic manipulation can enhance pollutant tolerance and metabolic capabilities of microalgae, improving their efficacy in bioremediation.

Integration with other technologies: Combined approaches integrating microalgal bioremediation with other treatment technologies (e.g., membrane filtration, activated carbon adsorption) offer synergistic benefits and improved overall treatment efficiencies.

Exploration of novel species: Research focusing on identifying and characterizing new microalgal species with enhanced pollutant uptake and degradation capabilities expands the diversity of bioremediation options.

Life cycle assessment: Comprehensive life cycle assessments are essential to evaluate the environmental sustainability and long-term impacts of microalgal bioremediation processes.[7-11]

Conclusion

Microalgal bioremediation holds immense promise as a sustainable and efficient method for mitigating the impact of emerging pollutants in wastewater and contaminated environments. Despite existing challenges, ongoing research and technological advancements continue to improve the feasibility and scalability of microalgal-based treatment systems. Addressing these obstacles and harnessing emerging opportunities will be crucial in realizing the full potential of microalgae for environmental remediation in the coming years.

References

1. Galiano F, Briceño K, Marino T (2018)Advances in biopolymer-based membrane preparation and applications.J Membr Sci 564: 562-586

Google Scholar

2. Shi J, Votruba AR., Farokhzad OC, Langer R (2010)Nanotechnology in drug delivery and tissue engineering: From discovery to applications.Nano Lett 10: 3223-3230.

Google Scholar

3. Capito RM, Azevedo HS, Velichko YS, Mata A, Stupp SI, et al. (2008)Self-assembly of large and small molecules into hierarchically ordered sacs and membranes.Science 319: 1812-1816.

Indexed at, Google Scholar, Crossref

4. Mironov V, Kasyanov V, Markwald RR(2008)Nanotechnology in vascular tissue engineering: from nanoscaffolding towards rapid vessel biofabrication.Trends Biotechnol 26: 338-344.

Google Scholar

5. Heiati H, Phillips N, Tawashi R (1996)Evidence for phospholipid bilayer formation in solid lipid nanoparticles formulated with phospholipid and triglyceride.Pharm Res 13: 1406-1410.

Google Scholar

6. Yang YY, Wang Y, Powell R, Chan P (2006)Polymeric core-shell nanoparticles for therapeutics. Clin Exp Pharmacol Physiol 33: 557-562.

Google Scholar

7. Lucas N, Bienaime C, Belloy C, Queneudec M, Silvestre F, et al. (2008)Polymer biodegradation: mechanisms and estimation techniques. Chemosphere 73: 429-442.

Indexed at, Google Scholar, Crossref

8. Yih TC, Al-Fandi MEngineered nanoparticles as precise drug delivery systems.J Cell Biochem 97: 1184-1190.

Google Scholar

9. Chen L, Remondetto GE, Subirade M (2006)Food protein-based materials as nutraceutical delivery systems.Trends Food Sci Technol 17: 272-283.

Google Scholar

10. Friess W (1998)Collagen—biomaterial for drug delivery. Eur J Pharm Biopharm 45: 113-136.

Google Scholar

11. Daamen WF, Veerkamp JH, van Hest JCM, van Kuppevelt TH (2007)Elastin as a biomaterial for tissue engineering. Biomaterials 28: 4378-4398.

Google Scholar